Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
206.00    -4.00 (-1.90%)
Bid:
204.00
Ask:
205.00
Spread: 1.00 (0.49%)
Market Cap: £549.02m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

28 Apr 2025 12:32

RNS Number : 4662G
Costain Group PLC
28 April 2025
Β 

Β 

Β 

Costain Group PLC (the 'Company')

28 April 2025

Β 

Scrip Dividend Reference Price

Β 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the final dividend for the year ending 31 December 2024 is 104.88 pence per ordinary share.

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 17 April 2025.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the final dividend for the year ending 31 December 2024 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 7 May 2025.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip.Β 

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any further documentation to receive this scrip dividend.

The final dividend for the year ending 31 December 2024, including the scrip dividend, will be paid on 29 May 2025 (the dividend payment date), subject to approval at the 2025 Annual General Meeting on 15 May 2025, to the ordinary shareholders of the Company on the register at close of business on 22 April 2025 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

Β 

Enquiries

Β 

Investors and analysts

Matt Jones, Costain

matt.jones@costain.com

+44 (0)7860 922341

Β 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997365

Charlie Twigg

+44 (0) 7946 494568

Β 

Β 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DIVPPUBPCUPAGGR
Date   Source Headline
3rd Jan 20197:00 amRNSYear End Trading Update
2nd Jan 20198:00 amRNSTotal Voting Rights
2nd Jan 20198:00 amRNSBlock listing Interim Review
19th Dec 20183:33 pmRNSHolding(s) in Company
30th Nov 20182:31 pmRNSTotal Voting Rights
30th Nov 20187:00 amRNSNotice of Analyst Event
7th Nov 20187:00 amRNSSix-year framework contract award
29th Oct 20187:00 amRNSBlock Listing Application
17th Oct 20187:00 amRNSA2/M2 connected corridor trial
16th Oct 20187:00 amRNS2018 Interim Dividend - Scrip Alternative
26th Sep 20183:57 pmRNSHolding(s) in Company
24th Sep 20181:00 pmRNSDirector/PDMR Shareholding
20th Sep 20188:41 amRNSScrip Dividend Reference Price
23rd Aug 20187:00 amRNSNetwork Rail 'Meerkat' Technology Contract
22nd Aug 20187:00 amRNSHalf-year Report
21st Aug 20187:00 amRNSConnected Vehicle Technology Contract
10th Jul 20189:03 amRNSHolding(s) in Company
3rd Jul 20187:00 amRNSTrading Update
2nd Jul 20188:00 amRNSBlock listing Interim Review
29th Jun 20183:37 pmRNSHolding(s) in Company
22nd Jun 20188:38 amRNSHolding(s) in Company
14th Jun 20187:00 amRNSCostain expands to new technology centre
5th Jun 20183:49 pmRNSDirector/PDMR Shareholding
4th Jun 20187:00 amRNSCostain awarded M6 smart motorway contract
31st May 20189:00 amRNSTotal Voting Rights
15th May 20187:00 amRNSDividend - Scrip Alternative
8th May 20184:29 pmRNSResult of AGM
8th May 20187:00 amRNSCostain awarded technology contract
8th May 20187:00 amRNSAGM Statement
30th Apr 20188:00 amRNSTotal Voting Rights
19th Apr 20188:55 amRNSScrip Dividend Reference Price
11th Apr 20181:16 pmRNSDirector/PDMR Shareholding
4th Apr 20182:52 pmRNSDirector/PDMR Shareholding
3rd Apr 20189:41 amRNSDirector Declaration
29th Mar 20189:01 amRNSTotal Voting Rights
26th Mar 20188:50 amRNSHolding(s) in Company
16th Mar 20189:18 amRNSNotice of AGM
13th Mar 201812:53 pmRNSExercise of Nil Cost Options
13th Mar 201811:58 amRNSHolding(s) in Company
12th Mar 20181:49 pmRNSHolding(s) in Company
6th Mar 20189:00 amRNSLong Term Incentive Plan - Listing Application
1st Mar 20187:00 amRNSFinal Results
28th Feb 20189:00 amRNSTotal Voting Rights
28th Feb 20188:38 amRNSHolding(s) in Company
26th Feb 201810:07 amRNSDirectorate Change
31st Jan 20189:00 amRNSTotal Voting Rights
11th Jan 201812:32 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSYear End Trading Update
2nd Jan 20188:00 amRNSTotal Voting Rights
2nd Jan 20188:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.